Galectin-3: A potential new target for upstream therapy of atrial fibrillation.

He, Bo

Galectin-3: A potential new target for upstream therapy of atrial fibrillation. [electronic resource] - International journal of cardiology Jan 2016 - 1131-2 p. digital

Publication Type: Letter

1874-1754

10.1016/j.ijcard.2015.09.058 doi


Atrial Fibrillation--blood
Atrial Remodeling
Biomarkers--blood
Fibrosis--metabolism
Galectin 3--blood
Humans
Predictive Value of Tests